C07D 473 - Heterocyclic compounds containing purine ring systems

Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
01/2010
01/05/2010	US7642265 Benzimidazoles and analogs thereof as antivirals
01/05/2010	CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
01/05/2010	CA2184681C Process for preparing substituted n-ethylglycine derivatives
12/2009
12/31/2009	US20090325983 New purine derivatives
12/31/2009	US20090325982 Phosphodiesterase 4 inhibitors
12/31/2009	US20090325967 Adenosine derivatives as a2a receptor agonists
12/31/2009	US20090325904 Maleic acid monosalt of antiviral agent and pharmaceutical composition containing the same
12/31/2009	US20090324551 Tlr agonists
12/30/2009	WO2009157880A1 Pyrazine substituted purines
12/30/2009	WO2009114874A3 Benzothiazole kinase inhibitors and methods of use
12/30/2009	EP2138497A1 Novel adenine compound
12/30/2009	EP2137186A1 Heterocyclic compounds and their uses
12/30/2009	EP1532149B1 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments
12/30/2009	EP1501812B1 Pna monomer and precursor
12/29/2009	CA2410311C Barbituric acid analogs as therapeutic agents
12/24/2009	US20090318556 Biomarkers for detecting radiation exposure: methods and uses thereof
12/24/2009	US20090318476 Azacycloalkane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase
12/24/2009	US20090318445 Pdf inhibitors
12/24/2009	US20090318411 Purine pi3k inhibitor compounds and methods of use
12/23/2009	EP2134715A2 O6-alkylguanine-dna alkyltransferase inactivators
12/23/2009	CN101607960A Acebrophylline, surfolase and composition thereof
12/23/2009	CN100571540C Coco alkaline having carcinogenesis suppressing function
12/22/2009	CA2487306C Novel piperidine compound
12/17/2009	WO2009121036A3 Substituted aryl pyrimidinone derivatives
12/17/2009	US20090312543 Pyrazole compounds useful as protein kinase inhibitors
12/17/2009	US20090312319 Certain chemical entities, compositions and methods
12/17/2009	CA2727495A1 Nucleoside cyclicphosphates
12/16/2009	EP2133353A1 Novel adenine compound
12/16/2009	EP2132209A1 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7 ) modulators
12/16/2009	CN101602766A Synthesis method of 6-chloropurine
12/16/2009	CN101602765A 6-alkyl amino-2-alkylthio-9-ester-containing alkylpurine derivatives and method for synthesizing same
12/16/2009	CN101602764A Method for preparing acyclovir 2/3 hydrate
12/16/2009	CN100569774C Production of 2-amino-6-fluoro-9-(4-hydroxy-3-methylol-butyl)purine and its intermediate
12/15/2009	CA2398908C Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver
12/10/2009	WO2009146542A1 6-(c2-6alkylseleno)purines and methods for treating neural measles viral infection therewith
12/10/2009	WO2009118759A3 Heterocyclic compounds as adenosine receptor antagonist
12/09/2009	EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009	CN100567293C N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
12/09/2009	CN100567270C Sulfonyl amide derivatives
12/08/2009	US7629461 High performance liquid chromatography; crystal structure
12/08/2009	CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/03/2009	WO2009146406A1 Purine pi3k inhibitor compounds and methods of use
12/03/2009	WO2009145289A1 Inhibitor of analgesic tolerance
12/03/2009	WO2009144632A1 Novel compounds
12/03/2009	US20090298927 Thermal Extraction Method and Product
12/03/2009	US20090298856 2,3 Substituted fused bicyclic pyrimidin-4(3H)-ones modulating the function of the vanilliod-1receptor (VR1)
12/03/2009	US20090298744 Heterocyclic compounds as adenosine receptor antagonist
12/03/2009	CA2726198A1 Inhibitor of analgesic tolerance
12/03/2009	CA2721851A1 Purine pi3k inhibitor compounds and methods of use
12/02/2009	EP2127534A1 Method for obtaining fibre-rich cocoa with low carbon hydrate and methylxanthine contents, suitable for animal feed, and resulting cocoa
12/01/2009	US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
12/01/2009	US7625906 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/01/2009	US7625881 3-ethyl-2,6-dioxo-1-propyl-8-(1-{[3-(trifluoromethyl)phenyl]methyl}pyrazol-4-yl)-1,3,7-trihydropurin-7-yl]methyl butanoate; treatment of asthma and diarrhea
11/2009
11/26/2009	US20090291922 Anti-proliferative compounds, compositions, and methods of use thereof
11/25/2009	EP2123653A1 Process for production of crystal of purine nucleoside compound
11/25/2009	EP2121717A2 Nucleoside and nucleotide analogues with quaternary carbon centers and methods of use
11/25/2009	CN101589044A Process for production of crystal of purine nucleoside compound
11/25/2009	CN101589043A Purine derivatives
11/19/2009	WO2009138122A1 Purine derivatives further comprising a mercapto-acylamino group as neutral endopeptidase inhibitors
11/19/2009	US20090286813 Thioxanthine Derivatives and Their Use as Inhibitors of MPO
11/19/2009	CA2723922A1 Purine derivatives further comprising a mercapto-acylamino group as neutral endopeptidase inhibitors
11/18/2009	EP2119717A1 8-[3-amino-piperidin-1-yl]-xanthins, their production and utilisation as DPP IV inhibitors
11/18/2009	EP2118107A1 Mercaptopurine derivatives as anticancer agents
11/18/2009	EP2118067A1 Nicotinic acetylcholine receptor modulators
11/18/2009	EP1529049B1 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors
11/18/2009	CN100560585C New benzimidazole derivative
11/17/2009	US7619092 Such as (2R,4S)-1-{N-(3,5-bistrifluoromethylbenzyl)-N-methyl}-aminocarbonyl-2-(4-fluoro-2-methylphenyl)-4-(2-hydroxyethoxy)-piperidine; tachykinin receptor antagonists
11/17/2009	US7618975 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis; antiproliferative, anticarcinogenic, antimetabolic agents; tubulin and topoisomerase II inhibitors; fungicides; synergistic administration with other anticarcinogenic agents
11/17/2009	US7618962 Pyrazolyl substituted xanthines
11/12/2009	WO2009136175A1 Compounds for use in stabilizing p53 mutants
11/12/2009	WO2009136144A1 Purine derivatives suitable for the treatment of cancer, autoimmune and inflammatory diseases
11/12/2009	WO2009087066A3 Method for preparing a marked purine derivative, said derivative and uses thereof
11/12/2009	WO2009062059A3 Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors
11/12/2009	US20090281312 Procedure for the treatment of purines and resulting product
11/12/2009	US20090281127 Organic Compounds
11/12/2009	US20090281126 Organic Compounds
11/12/2009	US20090281075 Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors
11/12/2009	US20090280086 Methods and compositions for treating hepatitis c virus
11/05/2009	US20090275564 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
11/03/2009	US7612079 2-(hydroxypiperidin-1-yl or hydroxyisoalkylamino)-6(3-nitrophenylamino, 3,4-dimethoxybenzylamino, pyrid-2-yl-methylamino, pyrid-4-yl-methylamino or indan-5-amino)-9-(isopropyl or cyclopentyl)purines; cell cyclin kinase inhibitors for treating cancer, leukemia, psoriasis and neuronal apoptosis
10/2009
10/29/2009	WO2009131687A2 Inhibitors of protein kinases
10/29/2009	US20090270428 Cyclopropanecarboxylate esters of acyclovir
10/29/2009	US20090270427 Purine derivatives
10/29/2009	US20090270352 Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal
10/29/2009	US20090269846 Inhibitors of tyrosine kinase receptor dimerization
10/29/2009	CA2723185A1 Inhibitors of protein kinases
10/28/2009	EP2112151A2 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
10/28/2009	CN101565359A Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation
10/27/2009	US7609279 Data-driven layout engine
10/27/2009	US7608687 Releasable linkage and compositions containing same
10/27/2009	US7608597 For therapy and prophylaxis of a Hepatitis C virus infection in a host
10/27/2009	US7608288 Caffeine fraction obtained from tea leaves and a method for inducing Agrobacterium tumefaciens-mediated genetic transformation in plants using said caffeine fraction
10/22/2009	WO2009108383A3 Substituted xanthine derivatives
10/22/2009	US20090264409 Bicyclic Heterocyclic p-38 Kinase Inhibitors
10/21/2009	CN101563349A Haloalkyl-substituted pyrimidinone derivatives
10/21/2009	CN101563346A Process for the preparation of abacavir
10/21/2009	CN101560210A Method for synthesizing diprophylline
10/20/2009	CA2214793C Novel intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds
10/15/2009	US20090258887 Novel Carboxylic Acid Derivatives
10/14/2009	CN101558069A Cis-cyclohexyl substituted pyrimidinone derivatives

1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 120